• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
From Sequence Data to Returnable Results: Ethical Issues in Variant Calling and Interpretation.从序列数据到可返回结果:变异检测与解读中的伦理问题。
Genet Test Mol Biomarkers. 2017 Mar;21(3):178-183. doi: 10.1089/gtmb.2016.0413. Epub 2017 Feb 16.
2
Pharmacogenetics and ethical considerations: why care?药物遗传学与伦理考量:为何要关注?
Pharmacogenomics J. 2007 Oct;7(5):293-6. doi: 10.1038/sj.tpj.6500425. Epub 2006 Oct 10.
3
Benefits and Risks of Sharing Genomic Information.共享基因组信息的益处与风险。
Genet Test Mol Biomarkers. 2015 Dec;19(12):648-9. doi: 10.1089/gtmb.2015.29008.sjt. Epub 2015 Nov 20.
4
[National Database of Genotypes--ethical and legal issues].[国家基因型数据库——伦理和法律问题]
Cas Lek Cesk. 2011;150(7):372-5; discussion 376-7.
5
Applying theological developments to bioethical issues such as genetic screening.将神学发展应用于基因筛查等生物伦理问题。
Ethics Med. 2005 Summer;21(2):95-107.
6
Ethical and juridical issues of genetic testing: a review of the international regulation.基因检测的伦理和法律问题:国际监管综述
Crit Rev Oncol Hematol. 2009 Feb;69(2):98-107. doi: 10.1016/j.critrevonc.2008.10.003. Epub 2008 Nov 25.
7
Predictive genetic testing in urology: ethical and social issues.泌尿外科中的预测性基因检测:伦理与社会问题
World J Urol. 2004 Feb;21(6):433-7. doi: 10.1007/s00345-003-0376-6. Epub 2003 Dec 23.
8
Society and ethics - the genetics of disease.社会与伦理——疾病的遗传学
Curr Opin Genet Dev. 2004 Jun;14(3):287-91. doi: 10.1016/j.gde.2004.04.014.
9
Ethical considerations of genetic testing.基因检测的伦理考量。
J Clin Ethics. 2002 Winter;13(4):316-23.
10
Clinical considerations for allied professionals: ethical issues in cardiogenetics.辅助医疗专业人员的临床考量:心脏遗传学中的伦理问题
Heart Rhythm. 2007 Aug;4(8):1110-1. doi: 10.1016/j.hrthm.2007.05.003. Epub 2007 May 3.

引用本文的文献

1
Issues in the Use of Human Tissues to Support Precision Medicine.使用人体组织支持精准医学中的问题。
J Health Care Poor Underserved. 2019;30(4S):66-78. doi: 10.1353/hpu.2019.0117.
2
Ethical considerations in genomic testing for hematologic disorders.血液系统疾病基因检测中的伦理考量
Blood. 2017 Jul 27;130(4):460-465. doi: 10.1182/blood-2017-01-734558. Epub 2017 Jun 9.

本文引用的文献

1
Coming of age: ten years of next-generation sequencing technologies.成年:下一代测序技术的十年
Nat Rev Genet. 2016 May 17;17(6):333-51. doi: 10.1038/nrg.2016.49.
2
Germline Findings in Tumor-Only Sequencing: Points to Consider for Clinicians and Laboratories.仅肿瘤测序中的种系发现:临床医生和实验室需考虑的要点
J Natl Cancer Inst. 2015 Nov 20;108(4). doi: 10.1093/jnci/djv351. Print 2016 Apr.
3
PacBio Sequencing and Its Applications.PacBio测序技术及其应用。
Genomics Proteomics Bioinformatics. 2015 Oct;13(5):278-89. doi: 10.1016/j.gpb.2015.08.002. Epub 2015 Nov 2.
4
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.序列变异解读的标准与指南:美国医学遗传学与基因组学学会和分子病理学协会的联合共识推荐
Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.
5
Actionable exomic incidental findings in 6503 participants: challenges of variant classification.6503名参与者中可采取行动的外显子组偶然发现:变异分类的挑战
Genome Res. 2015 Mar;25(3):305-15. doi: 10.1101/gr.183483.114. Epub 2015 Jan 30.
6
Mappability and read length.可映射性和读长。
Front Genet. 2014 Nov 10;5:381. doi: 10.3389/fgene.2014.00381. eCollection 2014.
7
Anticipate and communicate: Ethical management of incidental and secondary findings in the clinical, research, and direct-to-consumer contexts (December 2013 report of the Presidential Commission for the Study of Bioethical Issues).预见和沟通:临床、研究和直接面向消费者背景下偶然和次要发现的伦理管理(生物伦理问题总统委员会 2013 年 12 月报告)。
Am J Epidemiol. 2014 Sep 15;180(6):562-4. doi: 10.1093/aje/kwu217. Epub 2014 Aug 22.
8
Integrating human sequence data sets provides a resource of benchmark SNP and indel genotype calls.整合人类序列数据集提供了一个基准 SNP 和 indel 基因型调用资源。
Nat Biotechnol. 2014 Mar;32(3):246-51. doi: 10.1038/nbt.2835. Epub 2014 Feb 16.
9
ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.ACMG 临床外显子组和基因组测序中偶然发现报告的推荐标准。
Genet Med. 2013 Jul;15(7):565-74. doi: 10.1038/gim.2013.73. Epub 2013 Jun 20.
10
Do researchers have an obligation to actively look for genetic incidental findings?研究人员是否有义务积极寻找遗传偶然发现?
Am J Bioeth. 2013;13(2):32-42. doi: 10.1080/15265161.2012.754062.

从序列数据到可返回结果:变异检测与解读中的伦理问题。

From Sequence Data to Returnable Results: Ethical Issues in Variant Calling and Interpretation.

作者信息

Holm Ingrid A, Yu Timothy W, Joffe Steven

机构信息

1 Division of Genetics and Genomics, The Manton Center for Orphan Diseases Research , Boston Children's Hospital, Boston, Massachusetts.

2 Department of Pediatrics, Harvard Medical School , Boston, Massachusetts.

出版信息

Genet Test Mol Biomarkers. 2017 Mar;21(3):178-183. doi: 10.1089/gtmb.2016.0413. Epub 2017 Feb 16.

DOI:10.1089/gtmb.2016.0413
PMID:28306396
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5367907/
Abstract

A discussion of return of genetic research results requires a common understanding of how final results are generated and what the scope of potential results may be. To this end, we provide a brief overview of the steps by which human genomic data, whether in the clinical or research setting, are generated and interpreted. We cover (1) DNA targeting methods, (2) sequencing, (3) mapping, (4) variant calling, (5) annotation, and (6) interpretation. As powerful as this technology is, we point out technical, scientific, and clinical limitations that inject uncertainty into interpretations based on genotypic data alone. Given these considerations, we then discuss ethical issues that arise as decisions are made regarding how human genomic data are generated and interpreted in the research setting, and we propose an ethical framework by which researchers can assert policies at the points of control that maximize rewards, while minimizing risks.

摘要

对基因研究结果的反馈进行讨论,需要对最终结果是如何产生的以及潜在结果的范围可能是什么达成共识。为此,我们简要概述了在临床或研究环境中生成和解释人类基因组数据的步骤。我们涵盖了(1)DNA靶向方法、(2)测序、(3)定位、(4)变异检测、(5)注释和(6)解释。尽管这项技术很强大,但我们指出了一些技术、科学和临床方面的局限性,这些局限性使得仅基于基因型数据的解释存在不确定性。考虑到这些因素,我们接着讨论在研究环境中就如何生成和解释人类基因组数据做出决策时出现的伦理问题,并提出一个伦理框架,研究人员可以据此在控制环节制定政策,以实现收益最大化,同时将风险降至最低。